ソース:[1] UBS Upgrades Agilent Technologies (A) (https://fintel.io/news/ubs-upgrades-agilent-t ...)[2] UBS upgrades Agilent on China, pharma lab demand; sees 20%+ upside - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)[3] Evercore ISI Group Maintains Agilent Technologies (A) In-Line Recommendation - Nasdaq (https://www.nasdaq.com/articles/evercore-isi- ...)